van Leeuwen RWF - Search Results

1

Cost-Effective and Sustainable Drug Use in Hospitals: A Systematic and Practice-Based Approach.

Zietse M, van der Zeeuw SL, Gebbink AK, de Vries AC, Crombag MBS, van Leeuwen RWF, Hoedemakers MJ. Zietse M, et al. Among authors: van leeuwen rwf. Appl Health Econ Health Policy. 2024 Dec 19. doi: 10.1007/s40258-024-00937-6. Online ahead of print. Appl Health Econ Health Policy. 2024. PMID: 39702592

2

Combatting the rising costs of cancer drugs; interventions from a university hospital's perspective.

Dane A, van Leeuwen R, Hoedemakers M, van der Kuy H, Sleijfer S. Dane A, et al. Front Pharmacol. 2023 Aug 28;14:1264951. doi: 10.3389/fphar.2023.1264951. eCollection 2023. Front Pharmacol. 2023. PMID: 37701038 Free PMC article.

3

The administration of immune checkpoint inhibitors via an elastomeric pump versus conventional intravenous infusion: an economic perspective.

Zietse M, Malmberg R, van Leeuwen RWF, Thielen FW, Uyl-de Groot CA. Zietse M, et al. Among authors: van leeuwen rwf. BMC Health Serv Res. 2024 Oct 31;24(1):1322. doi: 10.1186/s12913-024-11719-0. BMC Health Serv Res. 2024. PMID: 39482711 Free PMC article.

4

Alternative dosing strategies for immune checkpoint inhibitors to improve cost-effectiveness: a special focus on nivolumab and pembrolizumab.

Malmberg R, Zietse M, Dumoulin DW, Hendrikx JJMA, Aerts JGJV, van der Veldt AAM, Koch BCP, Sleijfer S, van Leeuwen RWF. Malmberg R, et al. Among authors: van leeuwen rwf. Lancet Oncol. 2022 Dec;23(12):e552-e561. doi: 10.1016/S1470-2045(22)00554-X. Lancet Oncol. 2022. PMID: 36455584 Review.

5

Interchangeability of immune checkpoint inhibitors: an urgent need for action.

Zietse M, van Leeuwen RWF, Barjesteh van Waalwijk van Doorn-Khosrovani S, de Boer JE, Dupree R, Mathijssen RHJ, Timmers L. Zietse M, et al. Among authors: van leeuwen rwf. Lancet Oncol. 2024 Nov;25(11):e611-e616. doi: 10.1016/S1470-2045(24)00212-2. Epub 2024 Oct 14. Lancet Oncol. 2024. PMID: 39419062 Review.

6

Effect of Switching the Histamine-1 Receptor Antagonist Clemastine to Cetirizine in Paclitaxel Premedication Regimens: The H1-Switch Study.

Malmberg R, van Doorn L, Cox JM, Daloul A, Ettafahi H, Oomen-de Hoop E, Zietse M, Bos MEMM, Koch BCP, van Leeuwen RWF. Malmberg R, et al. Among authors: van leeuwen rwf. JCO Oncol Pract. 2024 Sep;20(9):1243-1251. doi: 10.1200/OP.24.00110. Epub 2024 Jun 7. JCO Oncol Pract. 2024. PMID: 38848522

7

Effect of alternative dosing strategies of pembrolizumab and nivolumab on health-care emissions in the Netherlands: a carbon footprint analysis.

Malmberg R, Loosveld JH, Schilte HP, Burdorf A, van Leeuwen RWF. Malmberg R, et al. Among authors: van leeuwen rwf. Lancet Planet Health. 2024 Nov;8(11):e915-e923. doi: 10.1016/S2542-5196(24)00245-6. Lancet Planet Health. 2024. PMID: 39515349 Free article.

8

Applying a cost-based pricing model for innovative cancer treatments subject to indication expansion: A case study for pembrolizumab and daratumumab.

Heine RJSD, Thielen FW, Mathijssen RHJ, van Leeuwen RWF, Franken MG, Uyl-de Groot CA. Heine RJSD, et al. Among authors: van leeuwen rwf. PLoS One. 2024 Feb 1;19(2):e0293264. doi: 10.1371/journal.pone.0293264. eCollection 2024. PLoS One. 2024. PMID: 38300937 Free PMC article.

9

Drug-drug interactions in patients treated for cancer: a prospective study on clinical interventions.

van Leeuwen RWF, Jansman FGA, van den Bemt PMLA, de Man F, Piran F, Vincenten I, Jager A, Rijneveld AW, Brugma JD, Mathijssen RHJ, van Gelder T. van Leeuwen RWF, et al. Among authors: van gelder t, van den bemt pmla. Ann Oncol. 2015 May;26(5):992-997. doi: 10.1093/annonc/mdv029. Epub 2015 Jan 26. Ann Oncol. 2015. PMID: 25628444 Free article.

10

Evidence- and consensus-based guidelines for drug-drug interactions with anticancer drugs; A practical and universal tool for management.

van Leeuwen RWF, le Comte M, Reyners AKL, van den Tweel A, van Vlijmen B, Kwee W, Wensveen B, Steeghs N, Visser O, van Gelder T, Jansman FGA. van Leeuwen RWF, et al. Semin Oncol. 2022 Apr;49(2):119-129. doi: 10.1053/j.seminoncol.2022.03.002. Epub 2022 Mar 30. Semin Oncol. 2022. PMID: 35397932 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters